NuCana (NCNA) Interest Expenses (2020 - 2025)
NuCana (NCNA) reported Interest Expenses of $16.8 million for Q4 2025, up 93675.64% on a YoY basis from N/an in Q4 2024, and up 622958.49% sequentially from $2698.7 in Q3 2025.
NuCana (NCNA) Interest Expenses (2020 - 2025) Analysis & Trends
NuCana (NCNA) has 6 years of Interest Expenses data on file, last reported at $16.8 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 93675.64% year-over-year to $16.8 million; the trailing twelve-month figure through Dec 2025 stood at -$55680.2 (down 47034.49% YoY), and the FY2025 full-year result was $16.7 million, up 76641.81% from the prior year.
- Interest Expenses climbed to $16.8 million in Q4 2025, from $2698.7 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $16.8 million in Q4 2025 to a low of -$16.9 million in Q2 2025.
- A 5-year average of -$1435.1 and a median of $5590.9 in 2021 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 93675.64% in 2025, while the deepest fall reached 267454.34% in 2025.
- Tracing NCNA's Interest Expenses over 5 years: stood at $4044.0 in 2021, then sank by 37.72% to $2518.6 in 2022, then tumbled by 1233.41% to -$28546.5 in 2023, then surged by 37.05% to -$17969.0 in 2024, then jumped by 93675.64% to $16.8 million in 2025.
- Business Quant data shows NCNA's Interest Expenses at $16.8 million in Q4 2025, $2698.7 in Q3 2025, and -$16.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.81 Mn |
| Dec 31, 2025 | 16.81 Mn |
| Sep 30, 2025 | 2,698.72 |
| Sep 30, 2025 | 2,698.72 |
| Jun 30, 2025 | -16.87 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Dec 31, 2024 | -17,969.03 |
| Dec 31, 2024 | -17,969.03 |
| Sep 30, 2024 | 5,197.20 |
| Sep 30, 2024 | 5,197.20 |
| Jun 30, 2024 | 6,311.10 |
| Jun 30, 2024 | 6,311.10 |
| Mar 31, 2024 | 6,342.59 |
| Mar 31, 2024 | 6,342.59 |
| Dec 31, 2023 | -28,546.49 |
| Dec 31, 2023 | -28,546.49 |
| Sep 30, 2023 | 8,866.79 |
| Sep 30, 2023 | 8,866.79 |
| Jun 30, 2023 | 10,010.91 |
| Jun 30, 2023 | 10,010.91 |